V L Yarnykh1,2, E P Krutenkova2, G Aitmagambetova2, P Repovic3, A Mayadev3, P Qian3, L K Jung Henson3,4, B Gangadharan3, J D Bowen3. 1. From the Department of Radiology (V.L.Y.), University of Washington, Seattle, Washington yarnykh@uw.edu. 2. Research Institute of Biology and Biophysics (E.P.K., G.A., V.L.Y.), Tomsk State University, Tomsk, Russian Federation. 3. Multiple Sclerosis Center (P.R., A.M., P.Q., L.K.J.H., B.G., J.D.B.), Swedish Neuroscience Institute, Seattle, Washington. 4. Piedmont Henry Hospital (L.K.J.H.), Stockbridge, Georgia.
Abstract
BACKGROUND AND PURPOSE: Fast macromolecular proton fraction mapping is a recent quantitative MR imaging method for myelin assessment. The objectives of this study were to evaluate the macromolecular proton fraction as a measure of demyelination in subcortical GM structures in multiple sclerosis and assess a potential relationship between demyelination and excess iron deposition using the macromolecular proton fraction and T2* mapping. MATERIALS AND METHODS: Macromolecular proton fraction and T2* maps were obtained from 12 healthy controls, 18 patients with relapsing-remitting MS, and 12 patients with secondary-progressive MS using 3T MR imaging. Parameter values in the caudate nucleus, globus pallidus, putamen, substantia nigra, and thalamus were compared between groups and correlated to clinical data. RESULTS: The macromolecular proton fraction in all subcortical structures and T2* in the globus pallidus, putamen, and caudate nucleus demonstrated a significant monotonic decrease from controls to patients with relapsing-remitting MS and from those with relapsing-remitting MS to patients with secondary-progressive MS. The macromolecular proton fraction in all subcortical structures significantly correlated with the Expanded Disability Status Scale and MS Functional Composite scores with absolute Pearson correlation coefficient (r) values in a range of 0.4-0.6. Significant correlations (r = -0.4 to -0.6) were also identified between the macromolecular proton fraction and the 9-Hole Peg Test, indicating a potential relationship with nigrostriatal pathway damage. Among T2* values, weak significant correlations with clinical variables were found only in the putamen. The macromolecular proton fraction did not correlate with T2* in any of the studied anatomic structures. CONCLUSIONS: The macromolecular proton fraction provides an iron-insensitive measure of demyelination. Myelin loss in subcortical GM structures in MS is unrelated to excess iron deposition. Subcortical GM demyelination is more closely associated with the disease phenotype and disability than iron overload.
BACKGROUND AND PURPOSE: Fast macromolecular proton fraction mapping is a recent quantitative MR imaging method for myelin assessment. The objectives of this study were to evaluate the macromolecular proton fraction as a measure of demyelination in subcortical GM structures in multiple sclerosis and assess a potential relationship between demyelination and excess iron deposition using the macromolecular proton fraction and T2* mapping. MATERIALS AND METHODS: Macromolecular proton fraction and T2* maps were obtained from 12 healthy controls, 18 patients with relapsing-remitting MS, and 12 patients with secondary-progressive MS using 3T MR imaging. Parameter values in the caudate nucleus, globus pallidus, putamen, substantia nigra, and thalamus were compared between groups and correlated to clinical data. RESULTS: The macromolecular proton fraction in all subcortical structures and T2* in the globus pallidus, putamen, and caudate nucleus demonstrated a significant monotonic decrease from controls to patients with relapsing-remitting MS and from those with relapsing-remitting MS to patients with secondary-progressive MS. The macromolecular proton fraction in all subcortical structures significantly correlated with the Expanded Disability Status Scale and MS Functional Composite scores with absolute Pearson correlation coefficient (r) values in a range of 0.4-0.6. Significant correlations (r = -0.4 to -0.6) were also identified between the macromolecular proton fraction and the 9-Hole Peg Test, indicating a potential relationship with nigrostriatal pathway damage. Among T2* values, weak significant correlations with clinical variables were found only in the putamen. The macromolecular proton fraction did not correlate with T2* in any of the studied anatomic structures. CONCLUSIONS: The macromolecular proton fraction provides an iron-insensitive measure of demyelination. Myelin loss in subcortical GM structures in MS is unrelated to excess iron deposition. Subcortical GM demyelination is more closely associated with the disease phenotype and disability than iron overload.
Authors: E Mark Haacke; Norman Y C Cheng; Michael J House; Qiang Liu; Jaladhar Neelavalli; Robert J Ogg; Asadullah Khan; Muhammad Ayaz; Wolff Kirsch; Andre Obenaus Journal: Magn Reson Imaging Date: 2005-01 Impact factor: 2.546
Authors: Hunter R Underhill; Robert C Rostomily; Andrei M Mikheev; Chun Yuan; Vasily L Yarnykh Journal: Neuroimage Date: 2010-10-26 Impact factor: 6.556
Authors: Mohit Neema; Ashish Arora; Brian C Healy; Zachary D Guss; Steven D Brass; Yang Duan; Guy J Buckle; Bonnie I Glanz; Lynn Stazzone; Samia J Khoury; Howard L Weiner; Charles R G Guttmann; Rohit Bakshi Journal: J Neuroimaging Date: 2009-01 Impact factor: 2.486
Authors: Marina Yu Khodanovich; Irina V Sorokina; Valentina Yu Glazacheva; Andrey E Akulov; Nikolay M Nemirovich-Danchenko; Alexander V Romashchenko; Tatyana G Tolstikova; Lilia R Mustafina; Vasily L Yarnykh Journal: Sci Rep Date: 2017-04-24 Impact factor: 4.379
Authors: Neva M Corrigan; Vasily L Yarnykh; Daniel S Hippe; Julia P Owen; Elizabeth Huber; T Christina Zhao; Patricia K Kuhl Journal: Neuroimage Date: 2020-12-29 Impact factor: 6.556
Authors: Jilu P Mole; Fabrizio Fasano; John Evans; Rebecca Sims; Emma Kidd; John P Aggleton; Claudia Metzler-Baddeley Journal: Sci Rep Date: 2020-11-13 Impact factor: 4.379
Authors: Liudmila P Smirnova; Vasily L Yarnykh; Daria A Parshukova; Elena G Kornetova; Arkadiy V Semke; Anna V Usova; Anna O Pishchelko; Marina Y Khodanovich; Svetlana A Ivanova Journal: Transl Psychiatry Date: 2021-06-30 Impact factor: 6.222
Authors: Marina Yu Khodanovich; Ilya L Gubskiy; Marina S Kudabaeva; Darya D Namestnikova; Alena A Kisel; Tatyana V Anan'ina; Yana A Tumentceva; Lilia R Mustafina; Vasily L Yarnykh Journal: J Cereb Blood Flow Metab Date: 2021-06-09 Impact factor: 6.960